This study investigates intraductal papillary mucinous neoplasms (IPMNs).
The focus is on evaluating biomarkers to predict malignancy in IPMNs using genetic, metabolic, and environmental factors.
- Who can participate: Adults over 18 years with a confirmed diagnosis of IPMN, whether undergoing surgery or not, can participate. Participants must provide informed consent.
- Study details: Participants will provide biological samples during their hospital stay or outpatient visits.
- Study timelines: The study will last 24 months.